Algert Global LLC acquired a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 39,284 shares of the financial services provider's stock, valued at approximately $3,240,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC increased its stake in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock valued at $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. increased its stake in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC increased its stake in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock valued at $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife in the third quarter valued at $30,000. Finally, Fortitude Family Office LLC increased its stake in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock valued at $34,000 after buying an additional 266 shares in the last quarter. 89.81% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on MET. Bank of America lowered their target price on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research note on Thursday, August 1st. Piper Sandler lifted their price objective on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Barclays lowered their price objective on MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a research report on Thursday, October 31st. Morgan Stanley lowered their price objective on MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a research report on Monday, August 19th. Finally, TD Cowen began coverage on MetLife in a research report on Wednesday, October 9th. They issued a "buy" rating and a $97.00 price objective for the company. Fourteen research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $88.46.
Check Out Our Latest Stock Report on MET
MetLife Stock Up 0.5 %
Shares of NYSE:MET traded up $0.43 during trading on Tuesday, hitting $87.77. 3,073,250 shares of the company's stock traded hands, compared to its average volume of 3,319,821. MetLife, Inc. has a 52 week low of $62.81 and a 52 week high of $87.88. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a market cap of $60.77 billion, a price-to-earnings ratio of 17.61, a price-to-earnings-growth ratio of 0.79 and a beta of 1.05. The company has a 50-day moving average price of $82.68 and a 200-day moving average price of $76.18.
MetLife Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.48%. The ex-dividend date is Tuesday, November 5th. MetLife's payout ratio is 43.95%.
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.